The company, which has terminated the global distribution of Rejuvenate and ABG II stems, said it would continue to evaluate the data related to these products.
Stryker's shares closed at $53.54 on Friday on the New York Stock Exchange.
(Reporting by Shailesh Kuber in Bangalore; Editing by Don Sebastian)
Copyright 2013 mojeNovosti.com
web developer: BTGcms